Step 1: Understanding the Concept:
DIVA (Differentiating Infected from Vaccinated Animals) diagnostics in FMD rely on detecting antibody responses to non-structural viral replication polyprotein antigens.
Key Formula or Approach:
\[ \text{Vaccinated (Killed Purified Inactivated Virion)} \implies \text{Anti-Structural Antibodies ONLY} \]
\[ \text{Infected (Replicating Virus)} \implies \text{Anti-Structural } + \text{Anti-NSP (3ABC, 3D, 2C) Antibodies} \]
Step 2: Detailed Explanation:
DIVA technology in Foot-and-Mouth Disease (FMD) control:
1. Inactivated Vaccines: Prepared from purified, chemically binary ethyleneimine (BEI)-inactivated whole virions containing only structural capsid proteins (VP1, VP2, VP3, VP4); non-structural proteins (NSPs) are removed during purification.
2. Live Viral Infection: Active viral replication in host cells produces abundant Non-Structural Proteins (NSPs) like 3ABC, 3AB, 3D, and 2C, inducing strong anti-NSP antibody titers.
3. Therefore, NSP-based ELISA (e.g., 3ABC competitive ELISA) selectively detects anti-NSP antibodies in actively infected or carrier animals while remaining completely negative in vaccinated animals.
Step 3: Final Answer:
Therefore, NSP based ELISA is used for DIVA in FMD, corresponding to option (B).